Literature DB >> 19352112

Clinical tolerance 2008.

Allan D Kirk1.   

Abstract

In 2008, three publications highlighted the transition of tolerance from experimental to experiential. These included the first study to both anticipate and reproducibly deliver human leukocyte antigen-disparate allograft survival without continuous immunosuppressive drug administration. The other two highlighted unique episodes of clinical tolerance. The results from these studies are summarized and discussed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19352112      PMCID： PMC2706092          DOI： 10.1097/TP.0b013e31819d415e

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  10 in total

Review 1.  Induction immunosuppression.

Authors:  Allan D Kirk
Journal:  Transplantation       Date:  2006-09-15       Impact factor: 4.939

Review 2.  Transplant glomerulopathy.

Authors:  F G Cosio; J M Gloor; S Sethi; M D Stegall
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

Review 3.  An appraisal of tolerance in liver transplantation.

Authors:  J Lerut; A Sanchez-Fueyo
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

Review 4.  Donor bone marrow infusion in deceased and living donor renal transplantation.

Authors:  Gaetano Ciancio; George W Burke; Jang Moon; Rolando Garcia-Morales; Anne Rosen; Violet Esquenazi; James Mathew; Yide Jin; Joshua Miller
Journal:  Yonsei Med J       Date:  2004-12-31       Impact factor: 2.759

Review 5.  Mixed chimerism and transplantation tolerance.

Authors:  A Benedict Cosimi; David H Sachs
Journal:  Transplantation       Date:  2004-03-27       Impact factor: 4.939

6.  Clinical operational tolerance after kidney transplantation.

Authors:  G Roussey-Kesler; M Giral; A Moreau; J-F Subra; C Legendre; C Noël; E Pillebout; S Brouard; J-P Soulillou
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

7.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

8.  Tolerance and chimerism after renal and hematopoietic-cell transplantation.

Authors:  John D Scandling; Stephan Busque; Sussan Dejbakhsh-Jones; Claudia Benike; Maria T Millan; Judith A Shizuru; Richard T Hoppe; Robert Lowsky; Edgar G Engleman; Samuel Strober
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

9.  Chimerism and tolerance in a recipient of a deceased-donor liver transplant.

Authors:  Stephen I Alexander; Neil Smith; Min Hu; Deborah Verran; Albert Shun; Stuart Dorney; Arabella Smith; Boyd Webster; Peter John Shaw; Ahti Lammi; Michael O Stormon
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

Review 10.  Outcomes of recipients of both bone marrow and solid organ transplants. A review.

Authors:  B Dey; M Sykes; T R Spitzer
Journal:  Medicine (Baltimore)       Date:  1998-09       Impact factor: 1.889
  10 in total
  6 in total

1.  An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching.

Authors:  C P Larsen; A Page; K H Linzie; M Russell; T Deane; L Stempora; E Strobert; M C T Penedo; T Ward; R Wiseman; D O'Connor; W Miller; S Sen; K Singh; L S Kean
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

Review 2.  Clinical operational tolerance after renal transplantation: current status and future challenges.

Authors:  Giuseppe Orlando; Peiman Hematti; Robert J Stratta; George W Burke; Pierpaolo Di Cocco; Pierpaolo Di Cocco; Francesco Pisani; Shay Soker; Kathryn Wood
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

Review 3.  Nonhuman primate transplant models finally evolve: detailed immunogenetic analysis creates new models and strengthens the old.

Authors:  L S Kean; K Singh; B R Blazar; C P Larsen
Journal:  Am J Transplant       Date:  2011-12-17       Impact factor: 8.086

4.  Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients.

Authors:  Julie Ho; Atul Sharma; Kristine Kroeker; Robert Carroll; Sacha De Serres; Ian W Gibson; Patricia Hirt-Minkowski; Anthony Jevnikar; S Joseph Kim; Greg Knoll; David N Rush; Chris Wiebe; Peter Nickerson
Journal:  BMJ Open       Date:  2019-04-11       Impact factor: 2.692

5.  Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection.

Authors:  Patricia Hirt-Minkowski; Sacha A De Serres; Julie Ho
Journal:  Can J Kidney Health Dis       Date:  2015-08-18

6.  Non-Invasive Diagnosis for Acute Rejection Using Urinary mRNA Signature Reflecting Allograft Status in Kidney Transplantation.

Authors:  Jung-Woo Seo; Yu Ho Lee; Dong Hyun Tae; Seon Hwa Park; Ju-Young Moon; Kyung Hwan Jeong; Chan-Duck Kim; Byung Ha Chung; Jae Berm Park; Yeong Hoon Kim; Junhee Seok; Sun Hyung Joo; Seung Hwan Lee; Jong Soo Lee; Sang-Ho Lee
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.